Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition.

A characteristic of mucosal-associated invariant T (MAIT) cells is the expression of TRAV1-2(+) T cell receptors (TCRs) that are activated by riboflavin metabolite-based antigens (Ag) presented by the MHC-I related molecule, MR1. Whether the MR1-restricted T cell repertoire and associated Ag responsiveness extends beyond these cells remains unclear. Here, we describe MR1 autoreactivity and folate-derivative reactivity in a discrete subset of TRAV1-2(+) MAIT cells. This recognition was attributable to CDR3β loop-mediated effects within a consensus TRAV1-2(+) TCR-MR1-Ag footprint. Furthermore, we have demonstrated differential folate- and riboflavin-derivative reactivity by a diverse population of "atypical" TRAV1-2(-) MR1-restricted T cells. We have shown that TRAV1-2(-) T cells are phenotypically heterogeneous and largely distinct from TRAV1-2(+) MAIT cells. A TRAV1-2(-) TCR docks more centrally on MR1, thereby adopting a markedly different molecular footprint to the TRAV1-2(+) TCR. Accordingly, diversity within the MR1-restricted T cell repertoire leads to differing MR1-restricted Ag specificity.

[1]  P. Doherty,et al.  T Cell Receptor αβ Diversity Inversely Correlates with Pathogen-Specific Antibody Levels in Human Cytomegalovirus Infection , 2012, Science Translational Medicine.

[2]  J. McCluskey,et al.  Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers , 2015, The Journal of experimental medicine.

[3]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[4]  O. Lantz,et al.  Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. , 2011, Blood.

[5]  M. Bonneville,et al.  An Invariant T Cell Receptor α Chain Defines a Novel TAP-independent Major Histocompatibility Complex Class Ib–restricted α/β T Cell Subpopulation in Mammals , 1999, The Journal of experimental medicine.

[6]  Jamie Rossjohn,et al.  CD1d-lipid antigen recognition by the γδ TCR , 2013, Nature Immunology.

[7]  O. Lantz,et al.  Stepwise Development of MAIT Cells in Mouse and Human , 2009, PLoS biology.

[8]  A. Bertoletti,et al.  IL-7 Licenses Activation of Human Liver Intrasinusoidal Mucosal-Associated Invariant T Cells , 2013, The Journal of Immunology.

[9]  Malcolm J. McConville,et al.  MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.

[10]  James McCluskey,et al.  Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor , 2012, The Journal of experimental medicine.

[11]  P. Klenerman,et al.  CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner , 2013, European journal of immunology.

[12]  Olivier Lantz,et al.  Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.

[13]  James McCluskey,et al.  Recognition of vitamin B metabolites by mucosal-associated invariant T cells , 2013, Nature Communications.

[14]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[15]  James McCluskey,et al.  Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells , 2013, The Journal of experimental medicine.

[16]  P. Klenerman,et al.  MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets , 2014, Mucosal Immunology.

[17]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[18]  O. Lantz,et al.  Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.

[19]  O. Lund,et al.  MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage , 2014, The Journal of experimental medicine.

[20]  B. Jakobsen,et al.  Innate-Like Control of Human iNKT Cell Autoreactivity via the Hypervariable CDR3β Loop , 2010, PLoS biology.

[21]  James McCluskey,et al.  T cell antigen receptor recognition of antigen-presenting molecules. , 2015, Annual review of immunology.

[22]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[23]  P. Streeter,et al.  Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress , 2012, Mucosal Immunology.

[24]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[25]  J. McCluskey,et al.  The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance. , 2002, Structure.

[26]  P. Klenerman,et al.  Mucosal-Associated Invariant T-Cells: New Players in Anti-Bacterial Immunity , 2014, Front. Immunol..

[27]  J. McCluskey,et al.  MAITs, MR1 and vitamin B metabolites. , 2014, Current opinion in immunology.

[28]  Jeff Holst,et al.  Generation of T-cell receptor retrogenic mice , 2006, Nature Protocols.

[30]  D. Sinderen,et al.  T-cell activation by transitory neo-antigens derived from distinct microbial pathways , 2014, Nature.

[31]  James McCluskey,et al.  A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells , 2014, The Journal of experimental medicine.

[32]  Jared Becksfort,et al.  Paired analysis of TCRα and TCRβ chains at the single-cell level in mice. , 2011, The Journal of clinical investigation.

[33]  A. Sewell,et al.  Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers , 2009, Journal of immunological methods.

[34]  Matthew S. Cook,et al.  Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells , 2010, PLoS biology.

[35]  Vincenzo Cerundolo,et al.  Biology of CD1- and MR1-restricted T cells. , 2014, Annual review of immunology.